文献速递肿瘤 PET/CT骨显像与常规 SPECT

FDG-PET与全身MRI在高级别骨肉瘤中的作用:特别聚焦于骨肉瘤

The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma.
PubMed 文献 · Semin Nucl Med · 2021-12-06

本文综述了FDG-PET/CT与全身MRI(WB-MRI)在骨肉瘤等高级别骨肉瘤评估中的作用,包括分期、活检引导、疗效评估、复发检测及预后判断。文中指出SUVmax在多项研究中与总生存期和无进展生存期相关,WB-MRI适用于脑、肝、肾等背景活性较高器官的评估。文章还分析了PET/CT与MRI在放疗靶区勾画中的作用及新型非FDG示踪剂的前景。

要点

  • 骨肉瘤和尤文肉瘤是最常见的原发性骨肿瘤,因预后普遍较差,需尽可能明确预后因素以选择最佳治疗和随访方案。
  • FDG PET/CT中脊柱和骨骼因生理背景低而成为理想评估部位,SUVmax作为增殖细胞率的替代指标。
  • WB-MRI提供解剖与功能序列组合,适用于脑、肝、肾和椎管等背景活性较高器官的病变评估。

核心结论

  • FDG-PET/CT与WB-MRI在骨肉瘤等骨肉瘤的全身诊断流程中可提供准确分期、疗效评估、复发与远处转移检测及预后指标。

研究设计与样本

  • 本文为综述,概述PET/CT与WB-MRI在骨肉瘤中的作用与附加价值,并分析其在放疗靶区勾画中的作用及新型非FDG示踪剂的前景。

主要发现

  • 骨肉瘤占成人恶性肿瘤不足2%,占儿童和青少年/年轻成人恶性肿瘤约15%至20%。
  • 骨肉瘤包括80多种临床病理实体,骨肉瘤和尤文肉瘤是最常见的原发性骨肿瘤。
  • 多项研究中SUVmax对总生存期和无进展生存期具有预测价值。
  • FDG PET/CT中脊柱和骨骼因生理背景低而成为理想评估部位,SUVmax用作增殖细胞率的替代指标,原发肿块内FDG分布的空间异质性用作恶性肿瘤的替代指标。
  • WB-MRI提供解剖与功能序列组合,特别适用于脑、肝、肾和椎管等背景活性较高器官的病变评估。

关键数值与推荐

  • SUVmax(半定量参数)用作增殖细胞率的替代指标。
  • 原发肿块内FDG分布的空间异质性用作恶性肿瘤的替代指标。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sarcoma represents less than 2% of adult malignancies and about 15% to 20% of malignancies in children and adolescents/young adults. This neoplasm accounts for more than 80 different clinico-pathological entities with different clinical behavior; osteosarcoma and ewing sarcoma are the most frequent primary bone tumors. Because of the general poor prognosis, it is important to find out as many prognostic factors as possible to choose the best therapeutical approach and to correctly schedule the follow-up examinations. Third level imaging such as MRI and PET/CT are of utmost importance in the evaluation of sarcoma patients. The spine and bones in general are optimal sites to be evaluated with FDG PET/CT since the physiological background is low. The standardized uptake value (SUV max, a semiquantitave parameter) is used as a surrogate for proliferative cell rate, and the spatial heterogeneity of FDG distribution within the primary mass as a surrogate for malignancy. In several studies SUVmax was a predictive value for overall survival and progression-free survival. Whole-body MRI is a well-established technique for systemic, radiation-free evaluation, which is mostly applied in the oncological field. WB-MRI provides a combination of anatomical and functional sequences and is useful specifically in the evaluation of disease in organs with relatively high background activity such as the brain, liver, kidney, and spinal canal. These technologies provide accurate staging (also useful to drive the biopsy towards the most active foci in large heterogeneous masses), therapy assessment, relapse detection of local recurrence and distance metastasis but also prognostic indexes, in the context of whole body diagnostic procedures. This paper will provide an overview of the role and added value of PET/CT and WB-MRI in bone sarcomas particular focus on osteosarcoma. We also analyzed the role of the PET/CT and MRI for target delineation of radiation therapy and we and we will do an analysis of future prospects as new tracer non FDG.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Farina A, Gasperini C, Aparisi Gómez MP, et al. The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma. Semin Nucl Med. 2021. PMID: 34879906. doi:10.1053/j.semnuclmed.2021.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。